APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells. [electronic resource]
Producer: 20110331Description: 206-15 p. digitalISSN:- 1600-0609
- Antineoplastic Agents -- administration & dosage
- Aza Compounds -- administration & dosage
- Base Sequence
- Bridged Bicyclo Compounds, Heterocyclic -- administration & dosage
- Cytarabine -- administration & dosage
- DNA Primers -- genetics
- Daunorubicin -- administration & dosage
- Drug Resistance, Neoplasm
- Drug Synergism
- Female
- Gene Expression -- drug effects
- Genes, p53
- Humans
- Karyotyping
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Mutation
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Tumor Cells, Cultured
- Tumor Suppressor Protein p14ARF -- metabolism
- Vidarabine -- administration & dosage
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.